Linkedin

Home
Startup Insight
Stories
Articles
Features

Loading…

Home Tags Borealis Biosciences

Borealis Biosciences

Borealis Biosciences, a next-generation RNA medicines company, today announced the appointment of Christian Hordo as CEO; a $30 million infusion from an extension of the Series A led by Westlake BioPartners; and the addition of three new board directors, David Allison, Ph.D., Tom Frohlich and Catherine Thut, Ph.D.

Borealis Biosciences Secures $30 Mn Series A Funding

Team SR - December 20, 2024

ABOUT US

Startup Rise - America is rapidly growing business media platform for entrepreneurs and startups to cover and publish their journeys through Video Talks, Interviews, Articles and News.

Contact us: contact@startuprise.io

FOLLOW US

© Copyright startuprise 2024 All Rights Reserved.

Exit mobile version